Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Balancing control and safety: hypothalamic-pituitary-adrenal axis effects of dual-route fluticasone in unified airway disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026

Same author

Computational solutions for fractional-order modeling of Visceral Leishmaniasis using Caputo derivatives.

Scientific reports·2026

Same author

Integrating pulmonary rehabilitation into post-tuberculosis care: Evidence-based rationale for policy change in high tuberculosis burden countries.

Lung India : official organ of Indian Chest Society·2026

Same author

Bluish-green pleural effusion.

Lung India : official organ of Indian Chest Society·2026

Same author

Black Pleura Sign in Silicosis.

The Journal of the Association of Physicians of India·2026

Same author

Decoding the Invisible: A Diagnostic Odyssey of Pulmonary Alveolar Microlithiasis From the Desert State of India, Rajasthan.

Cureus·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Pharmacotherapy for multidrug resistant tuberculosis.

Naveen Chhabra¹, M L Aseri, Ramakant Dixit

¹Department of Pharmacology, J. L. N. Medical College, Ajmer, Rajasthan, India.

Journal of Pharmacology & Pharmacotherapeutics

|May 26, 2012

Summary

This summary is machine-generated.

Multidrug-resistant tuberculosis (MDR-TB) is a growing global health crisis, often resulting from improper treatment. A history of prior tuberculosis treatment is the strongest predictor for developing MDR-TB.

Keywords:

Cycloserine ethionamide kanamycin multidrug resistance tuberculosis para-aminosalicylic acid

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Related Experiment Videos

Last Updated: May 22, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

Microbiology
Infectious Diseases
Public Health

Background:

Tuberculosis (TB) treatment faces a significant challenge with the rise of drug resistance.
Multidrug-resistant tuberculosis (MDR-TB) is a critical global health issue affecting both developing and developed nations.
MDR-TB is frequently linked to suboptimal treatment practices, insufficient drug availability, and inadequate patient monitoring, with HIV/AIDS being a contributing factor.

Purpose of the Study:

To review the current landscape of multidrug-resistant tuberculosis (MDR-TB).
To identify key factors contributing to the emergence and spread of MDR-TB.
To highlight challenges and considerations in MDR-TB treatment.

Main Methods:

A comprehensive review of published scientific literature was conducted.
Data on MDR-TB emergence, contributing factors, and treatment predictors were analyzed.
Existing research on MDR-TB treatment efficacy and adverse effects was synthesized.

Main Results:

The emergence of resistance to isoniazid and rifampicin is a primary global concern.
A history of previous tuberculosis treatment is identified as the most significant predictor for MDR-TB.
While MDR-TB treatments are effective, they are associated with notable adverse drug effects.

Conclusions:

MDR-TB represents a complex challenge requiring improved treatment strategies and patient management.
Addressing factors like prior treatment history and co-infections is crucial for combating MDR-TB.
Further research into safer and more effective MDR-TB therapies is warranted.